Trimethoprim–sulfamethoxazole
Folate pathway inhibitors · Sequential folate blockade
Recall prompt
What is the mechanism of action of Trimethoprim–sulfamethoxazole?
Reveal answer
Sulfamethoxazole competes with PABA at dihydropteroate synthase. Trimethoprim inhibits microbial dihydrofolate reductase.
Mechanism of action
Sulfamethoxazole competes with PABA at dihydropteroate synthase. Trimethoprim inhibits microbial dihydrofolate reductase.
Drug-specific action
Blocks sequential folate steps. Hyperkalemia from trimethoprim and sulfonamide hypersensitivity are high-yield distinctions.
Bacterial coverage
Look up spectrum- Group A strep
- Variable
- MSSA
- Typical
- MRSA
- Variable
- E. faecalis
- Gap
- VRE E. faecium
- Gap
- E. coli
- Variable
- H. influenzae
- Variable
- P. aeruginosa
- Gap
- B. fragilis group
- Gap
- Respiratory atypicals
- Gap
Typical means a recognized spectrum target. Variable means activity depends on resistance, species within a group, or formulation. Gap means no dependable activity for that target. These are study patterns. Clinical decisions require local susceptibility, infection site and drug exposure.
Enterococcal activity is unreliable in vivo. Do not infer streptococcal activity from MRSA activity.
Sources
Sketchy Pharm · class review, PDF p. 15 Katzung & Trevor, 13th ed. · ch. 46